|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.39 USD | +2.04% |
|
+2.05% | +24.69% |
| 07-17 | Deutsche Bank Raises Price Target on Colgate-Palmolive to $104 From $98, Maintains Buy Rating | MT |
| 07-12 | UBS Raises Price Target on Colgate-Palmolive to $114 From $105, Maintains Buy Rating | MT |
Colgate-Palmolive Company provided earnings guidance for the full year 2021. For the year, the Company still expects net sales to be up 1% to 4% including a low-single-digit negative impact from foreign exchange. The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%.
The company expects double-digit earnings per share growth on a GAAP basis. On a Base Business basis, the company expects earnings per share growth in the low to mid-single digits.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.69% | 81.54B | |
| +15.63% | 400B | |
| +19.16% | 145B | |
| +2.74% | 75.6B | |
| -31.16% | 36.1B | |
| -14.35% | 35.31B | |
| +1.51% | 33.42B | |
| +18.76% | 18.79B | |
| +29.53% | 17.78B | |
| +15.73% | 13.59B |
COLGATE-PALMOLIVE COMPANY 
